Calvin Sheng, MD
Interventional Cardiology · Indianapolis, INNPI 1932553146
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,228 of the $3,673 with a category attached, or 60.7%. Abbott accounts for 69.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,353 and has fallen 92.8% since, to $169 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IN, where the typical reported total is $6,172.
Across 79 payments — averaging $46.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Edwards Lifesciences$395
- Medtronic$171
- Boston Scientific$165
- Biotronik Inc.$154
- Cardiva Medical, Inc.$92
- plus $158 from 6 others
Across 24 payments — averaging $478.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$11K
What the payments were for
- Travel & lodging$1,44539%
- Food & beverage$2,22861%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $2,538 |
| Edwards Lifesciences | 7 | $395 |
| Medtronic | 5 | $171 |
| Boston Scientific | 4 | $165 |
| Biotronik Inc. | 3 | $154 |
| Cardiva Medical, Inc. | 5 | $92 |
| Philips North America LLC | 2 | $42 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $31 |
| Abiomed | 1 | $26 |
| Cardiovascular Systems Inc. | 3 | $22 |
| Terumo Medical Corporation | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$1,403
- DRAGONFLY OPSTAR$315
- SAPIEN 3 Ultra RESILIA$156
- XIENCE SKYPOINT$133
- PRESSUREWIRE$107
How this compares
$3,673 in reported general payments places this provider in the 30th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 44 | $462 |
| Atorvastatin Calcium | 20 | $121 |
| Carvedilol | 17 | $56 |
| Rosuvastatin Calcium | 13 | $49 |
| Amlodipine Besylate | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Indianapolis
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Michael BallIndianapolis$76K
- Anjan SinhaIndianapolis$54K
- Nitesh GadeelaIndianapolis$48K
- George RevtyakIndianapolis$45K
- Scott SharpIndianapolis$41K
- Amrish MalhiIndianapolis$37K
- Jeffrey BreallIndianapolis$21K
- Sandeep DubeIndianapolis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.